Growth media preparation is the cornerstone of any microbiology lab. Not having the media you need when you need it—because someone forgot to start a batch or one failed—creates a log jam that knocks everything off schedule for days. This is especially the case in food safety, monitoring, and quality assurance, where having the right media ready on time can make or break your safety testing workflow.
This year, the Hamburg based life sciences company Eppendorf SE is awarding its prestigious research prize for the 28th time. The independent jury chaired by Prof. Reinhard Jahn selected Dr. Maurice Michel, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden as the winner of the Eppendorf Award for Young European Investigators 2023. Maurice Michel, born 1986, receives the 20,000 euro award for his research on artificial functions of DNA repair enzymes for the treatment of Disease..
Illumina Inc., a global leader in DNA sequencing and array-based technologies, today recognized the progress and impact of genomic technologies on pathogen preparedness and response. Following the boost in sequencing infrastructure and capabilities driven by the COVID-19 pandemic, today genomic technologies are enabling public health agencies and health care systems to better prepare for, and respond to, pathogenic threats...
The Institute for Cancer Research (ICR), part of the University of London, is using VIAFLO electronic pipettes from INTEGRA Biosciences to streamline its preclinical drug screening and translational medicine workflows. These pipettes are used to help identify new drug targets and advance into clinical trials, significantly increasing the center’s throughput and reproducibility of results...
Reactant concentrations can be easily monitored and adjusted by simply controlling the input/output flow rates into/out of the reactor, which gives chemists greater accuracy when carrying out complex reactions. The stirring of solutions within the reactor also ensures that reactants remain evenly mixed, resulting in consistent products across different batches. Furthermore, since reactions occur in real time with CSTRs, their residence times are much shorter compared to batch processing methods...
INTEGRA Biosciences has developed a comprehensive article exploring the key benefits of electronic benchtop liquid handling systems, as well as the telltale signs that indicate it's time to make the switch, to help you make the transition to a more efficient, accurate and user-friendly pipetting solution. INTEGRA offers a range of innovative benchtop liquid handling systems – from the MINI 96 electronic pipette and VIAFLO 96 and VIAFLO 384 handheld electronic pipettes to the ASSIST PLUS pipetting robot – that are designed to fit any budget...
Two key challenges in chemistry innovation are solved simultaneously by exploring chemical opportunities with artificial intelligence. Researchers in Japan have developed a machine learning process that simultaneously designs new molecules and suggests the chemical reactions to make them. The team, at the Institute of Statistical Mathematics (ISM) in Tokyo, published their results in the journal Science and Technology of Advanced Materials...
LynxDx, a Michigan diagnostics laboratory specializing in prostate cancer screening and risk prediction, acquired liquid handling solutions from INTEGRA Biosciences to streamline its sample preparation for high throughput COVID-19 testing. The lab is now in the process of moving these products over to prostate cancer screening, where they are helping to improve result accuracy and turnaround times and, ultimately, support timely diagnosis and treatment...
The Earlham Institute has been awarded £31.4m from the Biotechnology and Biological Sciences Research Council (BBSRC), part of UKRI, to deliver an ambitious programme of research, develop new technology, and deliver innovation and impact over the next five years. This investment covers two new strategic programmes of research - Cellular Genomics and Decoding Biodiversity - and two National Bioscience Research Infrastructures (NBRIs) - Transformative Genomics and the Earlham Biofoundry...
Have you read a ton of articles on phase contrast microscopy, but still can’t get the full picture? Well then, watch the second movie in the mini-movie series, “Microscopy With ibidi,” for a simple explanation of how this microscopy technique works. In this short movie, we will show you why this microscopy technique is so important for scientists. and how phase contrast makes almost transparent cells clearly visible...
An international team of scientists from The Institute of Cancer Research, London, and the Max Planck Institute for Multidisciplinary Sciences in Germany employed state-of-the-art biochemical and cryo-electron microscopy (cryo-EM) methods to study the spliceosome in intricate detail and answer long standing questions about how it works. The spliceosome operates like a nanobot, processing RNA – genetic instructions copied from DNA – in a key step to allow the building of complex proteins...
As the second leading cause of death worldwide, cancer has touched the lives of most Americans. In an effort to improve treatments for patients on Earth by better understanding how cancer spreads, a team of researchers is sending cancer organoids to space in an investigation sponsored by the International Space Station (ISS) National Laboratory. In collaboration with Axiom Space, researchers from the University of California San Diego and the Sanford Stem Cell Institute, will study the properties of cancer stem cells...
GenNext Technologies, Inc., a growth-stage company that provides structural biology instrumentation, software, and services, announce that it is collaborating with Emery Pharma, a full-service CRO offering end-to-end biologic drug development support. Through this partnership, GenNext and Emery Pharma will combine forces to provide best-in-class pharmaceutical functional and structural analysis for allosteric and mono-clonal antibody therapeutics...
A new method of controlling the shape of tiny particles about one tenth of the width of human hair could make the technology that powers our daily lives more stable and more efficient, scientists claim. The process, which transforms the structure of microscopic semiconductor materials known as quantum dots, provides industry with opportunities to optimise optoelectronics, energy harvesting, photonics, and biomedical imaging technologies, according to the Cardiff University-led team...
Blood clot researchers could benefit from a new device that mimics a human vein, replacing the need for animals for some studies. The vein-on-a-chip model has been developed by scientists at the University of Birmingham and can be used in experiments to understand mechanisms of blood clot formation. The device, described in a recent paper published in Frontiers in Cardiovascular Medicine, is a tiny channel, which includes structures called ‘valves’ that ensure the correct direction of blood flow...
Revvity, Inc. has announced a new license agreement with AstraZeneca for the technology underlying its Pin-point™ base editing system, a next-generation modular gene editing platform with a strong safety profile. Dr. Alan Fletcher, Senior Vice President, Life Sciences at Revvity, said, “Our fundamental goal for the Pin-point platform is to translate the technology from pre-clinical research into the clinic, and ultimately, impact patient lives...
INTEGRA Biosciences’ PIPETBOY acu 2 pipette controller is helping researchers in the Immune Sensing and Signaling Dynamics group/ImmunoHUB at the i3S in Porto, Portugal, to further their research into the role of the aryl hydrocarbon receptor (AHR) in infection and cancer. Research technician Sérgio Marinho explained: “The AHR is used by cells to monitor their microenvironment, providing molecular cues to identify changes in microbial communities or tumor status, as well as allowing the host to react to potential imbalances in homeostasis...
Intellegens has announced that it will lead a consortium to help accelerate the adoption of artificial intelligence (AI) methods such as machine learning (ML) in the UK materials and chemicals industries. The initial phase of the project, funded by Innovate UK KTN, part of UK Research and Innovation, will study factors that limit use of this technology. It will also recommend steps to increase trust and drive the application of AI/ML to optimise vital products and processes while reducing energy and resource consumption in pursuit of net zero goals...
Deluge of entries ensures one of the Society’s biggest and best ever competitions. This year’s RMS Scientific Imaging Competition has triggered a fantastic response from microscopists around the world – with 198 images submitted across seven different award categories. With the submissions deadline now expired, the competition judges have been left with the tricky task of whittling down a shortlist of images to be displayed at mmc2023, where the final decisions on the winners will be made...
Aston University has been named as one of the UK’s leading lights in what is predicted to be the future of food - lab-made meat. The University is one of 17 higher education institutions that are expected to play a major role in the development of cultivated meat. Cultivated or lab-grown meat is made from cells taken from animals via biopsy. The cells are used to create meat which doesn’t involve the slaughter of animals...
Scientists have developed new technology which has made it possible to isolate and study how a single protein – 10,000 times thinner than a human hair – behaves and changes over time. The Nottingham Trent University team says the work – the first of its kind – enables them to see how a protein behaves in its natural environment and that it could help better understand proteins linked to disease and how they might respond to certain therapies...
England’s first centre of its kind is set to make significant improvements in cancer diagnosis and treatment – by combining pioneering digital imaging with artificial intelligence. The Royal Marsden NHS Foundation Trust and its academic research partner The Institute of Cancer Research, London, have today announced the opening of their new joint Integrated Pathology Unit (IPU)...
Growth media preparation is the cornerstone of any microbiology lab. Not having the media you need when you need it—because someone forgot to start a batch or one failed—creates a log jam that knocks everything off schedule for days. This is especially the case in food safety, monitoring, and quality assurance, where having the right media ready on time can make or break your safety testing workflow.
This year, the Hamburg based life sciences company Eppendorf SE is awarding its prestigious research prize for the 28th time. The independent jury chaired by Prof. Reinhard Jahn selected Dr. Maurice Michel, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden as the winner of the Eppendorf Award for Young European Investigators 2023. Maurice Michel, born 1986, receives the 20,000 euro award for his research on artificial functions of DNA repair enzymes for the treatment of Disease..
Illumina Inc., a global leader in DNA sequencing and array-based technologies, today recognized the progress and impact of genomic technologies on pathogen preparedness and response. Following the boost in sequencing infrastructure and capabilities driven by the COVID-19 pandemic, today genomic technologies are enabling public health agencies and health care systems to better prepare for, and respond to, pathogenic threats...
The Institute for Cancer Research (ICR), part of the University of London, is using VIAFLO electronic pipettes from INTEGRA Biosciences to streamline its preclinical drug screening and translational medicine workflows. These pipettes are used to help identify new drug targets and advance into clinical trials, significantly increasing the center’s throughput and reproducibility of results...
Reactant concentrations can be easily monitored and adjusted by simply controlling the input/output flow rates into/out of the reactor, which gives chemists greater accuracy when carrying out complex reactions. The stirring of solutions within the reactor also ensures that reactants remain evenly mixed, resulting in consistent products across different batches. Furthermore, since reactions occur in real time with CSTRs, their residence times are much shorter compared to batch processing methods...
INTEGRA Biosciences has developed a comprehensive article exploring the key benefits of electronic benchtop liquid handling systems, as well as the telltale signs that indicate it's time to make the switch, to help you make the transition to a more efficient, accurate and user-friendly pipetting solution. INTEGRA offers a range of innovative benchtop liquid handling systems – from the MINI 96 electronic pipette and VIAFLO 96 and VIAFLO 384 handheld electronic pipettes to the ASSIST PLUS pipetting robot – that are designed to fit any budget...
Two key challenges in chemistry innovation are solved simultaneously by exploring chemical opportunities with artificial intelligence. Researchers in Japan have developed a machine learning process that simultaneously designs new molecules and suggests the chemical reactions to make them. The team, at the Institute of Statistical Mathematics (ISM) in Tokyo, published their results in the journal Science and Technology of Advanced Materials...
LynxDx, a Michigan diagnostics laboratory specializing in prostate cancer screening and risk prediction, acquired liquid handling solutions from INTEGRA Biosciences to streamline its sample preparation for high throughput COVID-19 testing. The lab is now in the process of moving these products over to prostate cancer screening, where they are helping to improve result accuracy and turnaround times and, ultimately, support timely diagnosis and treatment...
The Earlham Institute has been awarded £31.4m from the Biotechnology and Biological Sciences Research Council (BBSRC), part of UKRI, to deliver an ambitious programme of research, develop new technology, and deliver innovation and impact over the next five years. This investment covers two new strategic programmes of research - Cellular Genomics and Decoding Biodiversity - and two National Bioscience Research Infrastructures (NBRIs) - Transformative Genomics and the Earlham Biofoundry...
Have you read a ton of articles on phase contrast microscopy, but still can’t get the full picture? Well then, watch the second movie in the mini-movie series, “Microscopy With ibidi,” for a simple explanation of how this microscopy technique works. In this short movie, we will show you why this microscopy technique is so important for scientists. and how phase contrast makes almost transparent cells clearly visible...
An international team of scientists from The Institute of Cancer Research, London, and the Max Planck Institute for Multidisciplinary Sciences in Germany employed state-of-the-art biochemical and cryo-electron microscopy (cryo-EM) methods to study the spliceosome in intricate detail and answer long standing questions about how it works. The spliceosome operates like a nanobot, processing RNA – genetic instructions copied from DNA – in a key step to allow the building of complex proteins...
As the second leading cause of death worldwide, cancer has touched the lives of most Americans. In an effort to improve treatments for patients on Earth by better understanding how cancer spreads, a team of researchers is sending cancer organoids to space in an investigation sponsored by the International Space Station (ISS) National Laboratory. In collaboration with Axiom Space, researchers from the University of California San Diego and the Sanford Stem Cell Institute, will study the properties of cancer stem cells...
GenNext Technologies, Inc., a growth-stage company that provides structural biology instrumentation, software, and services, announce that it is collaborating with Emery Pharma, a full-service CRO offering end-to-end biologic drug development support. Through this partnership, GenNext and Emery Pharma will combine forces to provide best-in-class pharmaceutical functional and structural analysis for allosteric and mono-clonal antibody therapeutics...
A new method of controlling the shape of tiny particles about one tenth of the width of human hair could make the technology that powers our daily lives more stable and more efficient, scientists claim. The process, which transforms the structure of microscopic semiconductor materials known as quantum dots, provides industry with opportunities to optimise optoelectronics, energy harvesting, photonics, and biomedical imaging technologies, according to the Cardiff University-led team...
Blood clot researchers could benefit from a new device that mimics a human vein, replacing the need for animals for some studies. The vein-on-a-chip model has been developed by scientists at the University of Birmingham and can be used in experiments to understand mechanisms of blood clot formation. The device, described in a recent paper published in Frontiers in Cardiovascular Medicine, is a tiny channel, which includes structures called ‘valves’ that ensure the correct direction of blood flow...
Revvity, Inc. has announced a new license agreement with AstraZeneca for the technology underlying its Pin-point™ base editing system, a next-generation modular gene editing platform with a strong safety profile. Dr. Alan Fletcher, Senior Vice President, Life Sciences at Revvity, said, “Our fundamental goal for the Pin-point platform is to translate the technology from pre-clinical research into the clinic, and ultimately, impact patient lives...
INTEGRA Biosciences’ PIPETBOY acu 2 pipette controller is helping researchers in the Immune Sensing and Signaling Dynamics group/ImmunoHUB at the i3S in Porto, Portugal, to further their research into the role of the aryl hydrocarbon receptor (AHR) in infection and cancer. Research technician Sérgio Marinho explained: “The AHR is used by cells to monitor their microenvironment, providing molecular cues to identify changes in microbial communities or tumor status, as well as allowing the host to react to potential imbalances in homeostasis...
Intellegens has announced that it will lead a consortium to help accelerate the adoption of artificial intelligence (AI) methods such as machine learning (ML) in the UK materials and chemicals industries. The initial phase of the project, funded by Innovate UK KTN, part of UK Research and Innovation, will study factors that limit use of this technology. It will also recommend steps to increase trust and drive the application of AI/ML to optimise vital products and processes while reducing energy and resource consumption in pursuit of net zero goals...
Deluge of entries ensures one of the Society’s biggest and best ever competitions. This year’s RMS Scientific Imaging Competition has triggered a fantastic response from microscopists around the world – with 198 images submitted across seven different award categories. With the submissions deadline now expired, the competition judges have been left with the tricky task of whittling down a shortlist of images to be displayed at mmc2023, where the final decisions on the winners will be made...
Aston University has been named as one of the UK’s leading lights in what is predicted to be the future of food - lab-made meat. The University is one of 17 higher education institutions that are expected to play a major role in the development of cultivated meat. Cultivated or lab-grown meat is made from cells taken from animals via biopsy. The cells are used to create meat which doesn’t involve the slaughter of animals...
Scientists have developed new technology which has made it possible to isolate and study how a single protein – 10,000 times thinner than a human hair – behaves and changes over time. The Nottingham Trent University team says the work – the first of its kind – enables them to see how a protein behaves in its natural environment and that it could help better understand proteins linked to disease and how they might respond to certain therapies...
England’s first centre of its kind is set to make significant improvements in cancer diagnosis and treatment – by combining pioneering digital imaging with artificial intelligence. The Royal Marsden NHS Foundation Trust and its academic research partner The Institute of Cancer Research, London, have today announced the opening of their new joint Integrated Pathology Unit (IPU)...